Diesse Diagnostica Senese S.p.A

Click Here To EMAIL INQUIRY
Contact: Raul Alvarez
Web: http://www.diesse.it
E-Mail:
Address: Via Del Pozzo 5, Loc. S. Martino, Monteriggioni 53035, Italy
Phone: +39-(577)-319560 | Fax: +39-(577)-318763 | Map/Directions >>

Profile: Diesse Diagnostica Senese S.p.A is a manufacturer of instrument systems and reagents for infectious diseases testing. We offer Ves Matic® - line of instruments and system for blood collection & analysis. The Ves-Matic Cube 200 is an automatic instrument for the analysis of the ESR test, according to the westergren method, directly into the same tubes. It can be used for the execution of the hemocrome test. All the phases of the ESR are measured with an optical system starting from the phase of the rouleaux formation, through the phase of sedimentation till the phase of red cells packing. The ESR test is performed in total absence of refluents to be eliminated and aerosol produced by eventual perforations of the tube caps containing the samples to be tested. When installed in the lab, the Ves-Matic Cube 200® will be predisposed and adapted to the typology of the rack of the used cell counters. By means of a fully automated analyzer and a specially designed blood collection tube, the Ves-Matic system® upgrades the quality of the Sed Rate procedure to standards of modern laboratory medicine and offes a unique combination of sfatey & walk away convenience.

The company was founded in 1982 and is ISO 9001, ISO 13485 and CE Mark certified.

FDA Registration Number: 9615056
US Agent: Deborah S Kipp / Streck
Phone: +1-(402)-537-5215 E-Mail:

39 Products/Services (Click for related suppliers)

• Adenovirus 1-33 CF Antigen (FDA Code: GOD / 866.3020)

Adenovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to adenovirus in serum. Additionally, some of these reagents consist of adenovirus antisera conjugated with a fluorescent dye and are used to identify adenoviruses directly from clinical specimens. The identification aids in the diagnosis of disease caused by adenoviruses and provides epidemiological information on these diseases. Adenovirus infections may cause pharyngitis (inflammation of the throat), acute respiratory diseases, and certain external diseases of the eye (e.g., conjunctivitis).

• Aerobic Transport System (FDA Code: JTW / 866.2900)

A microbiological specimen collection and transport device is a specimen collecting chamber intended for medical purposes to preserve the viability or integrity of microorganisms in specimens during storage of specimens after their collection and during their transport from the collecting area to the laboratory. The device may be labeled or otherwise represented as sterile. The device aids in the diagnosis of disease caused by pathogenic microorganisms.

• Automated Sedimentation Rate Device (FDA Code: GKB / 864.5800)

An automated sedimentation rate device is an instrument that measures automatically the erythrocyte sedimentation rate in whole blood. Because an increased sedimentation rate indicates tissue damage or inflammation, the erythrocyte sedimentation rate device is useful in monitoring treatment of a disease.

• B.Pertussis Antigen (FDA Code: GOX / 866.3065)

• Brucella Spp Agglutination Antigen (FDA Code: GSO / 866.3085)

• Coxsackievirus A 1-24 CF Antigen (FDA Code: GNG / 866.3145)

Coxsackievirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to coxsackievirus in serum. Additionally, some of these reagents consist of coxsackievirus antisera conjugated with a fluorescent dye that are used to identify coxsackievirus from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of coxsackievirus infections and provides epidemiological information on diseases caused by these viruses. Coxsackieviruses produce a variety of infections, including common colds, meningitis (inflammation of brain and spinal cord membranes), herpangina (brief fever accompanied by ulcerated lesions of the throat), and myopericarditis (inflammation of heart tissue).

• Echinococcus SPP Agglutinating Antigen (FDA Code: GPF / 866.3200)

• Echovirus 1-34 CF Antigen (FDA Code: GNL / 866.3205)

Echovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to echovirus in serum. Additionally, some of these reagents consist of echovirus antisera conjugated with a fluorescent dye used to identify echoviruses from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of echovirus infections and provides epidemiological information on diseases caused by these viruses. Echoviruses cause illnesses such as meningitis (inflammation of the brain and spinal cord membranes), febrile illnesses (accompanied by fever) with or without rash, and the common cold.

• Enriched Culture Media (FDA Code: KZI / 866.2330)

An enriched culture medium is a device that consists primarily of liquid or solid biological materials intended for medical purposes to cultivate and identify fastidious microorganisms (those having complex nutritional requirements). The device consists of a relatively simple basal medium enriched by the addition of such nutritional components as blood, blood serum, vitamins, and extracts of plant or animal tissues. The device is used in the diagnosis of disease caused by pathogenic microorganisms and also provides epidemiological information on these diseases.

• Erythrocyte Sedimentation Rate Test (FDA Code: JPH / 864.6700)

An erythrocyte sedimentation rate test is a device that measures the length of time required for the red cells in a blood sample to fall a specified distance or a device that measures the degree of sedimentation taking place in a given length of time. An increased rate indicates tissue damage or inflammation.

• Febrile Antigen (FDA Code: GSZ / 866.3410)

• Incubator/ Water Bath (FDA Code: JTQ / 866.2540)

A microbiological incubator is a device with various chambers or water-filled compartments in which controlled environmental conditions, particularly temperature, are maintained. It is intended for medical purposes to cultivate microorganisms and aid in the diagnosis of disease.

• Influenza Virus CF Antigen (FDA Code: GNX / 866.3330)

Influenza virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to influenza in serum. The identification aids in the diagnosis of influenza (flu) and provides epidemiological information on influenza. Influenza is an acute respiratory tract disease, which is often epidemic.

• Legionella Direct & Indirect Fluorescent Antibody Regents (FDA Code: LHL / 866.3300)

• Legionella Spp. ELISA (FDA Code: MJH / 866.3300)

• Leptospira Spp Antigen (FDA Code: GRY / 866.3350)

• Listeria Monocytogenes Slide and Tube Antigen (FDA Code: GSI / 866.3355)

• Lymphocytic Choriomeningitis Virus CF Antigen Test (FDA Code: GQK / 866.3360)

Lymphocytic choriomeningitis virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to lymphocytic choriomeningitis virus in serum. The identification aids in the diagnosis of lymphocytic choriomeningitis virus infections and provides epidemiological information on diseases caused by these viruses. Lymphocytic choriomeningitis viruses usually cause a mild cerebral meningitis (inflammation of membranes that envelop the brain) and occasionally a mild pneumonia, but in rare instances may produce severe and even fatal illnesses due to complications from cerebral meningitis and pneumonia.

• Mumps Virus Enzyme Linked Immunoabsorbent Assay (FDA Code: LJY / 866.3380)

Mumps virus serological reagents consist of antigens and antisera used in serological tests to identify antibodies to mumps virus in serum. Additionally, some of these reagents consist of antisera conjugated with a fluorescent dye (immunofluorescent reagents) used in serological tests to identify mumps viruses from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of mumps and provides epidemiological information on mumps. Mumps is an acute contagious disease, particularly in children, characterized by an enlargement of one or both of the parotid glands (glands situated near the ear), although other organs may also be involved.

• Mycoplasma Spp CF Antigen (FDA Code: GSB / 866.3375)

• Mycoplasma Spp Enzyme Linked Immunoabsorbent Assay (FDA Code: LJZ / 866.3375)

• Non-Selective and Differential Culture Media (FDA Code: JSH / 866.2320)

A differential culture medium is a device that consists primarily of liquid biological materials intended for medical purposes to cultivate and identify different types of pathogenic microorganisms. The identification of these microorganisms is accomplished by the addition of a specific biochemical component(s) to the medium. Microorganisms are identified by a visible change (e.g., a color change) in a specific biochemical component(s) which indicates that specific metabolic reactions have occurred. Test results aid in the diagnosis of disease and also provide epidemiological information on diseases caused by these microorganisms.

• Parainfluenza Virus CF Antigen (FDA Code: GQS / 866.3400)

Parainfluenza virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to parainfluenza virus in serum. The identification aids in the diagnosis of parainfluenza virus infections and provides epidemiological information on diseases caused by these viruses. Parainfluenza viruses cause a variety of respiratory illnesses ranging from the common cold to pneumonia.

• Poliovirus 1-3 CF Antigen (FDA Code: GOH / 866.3405)

Poliovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to poliovirus in serum. Additionally, some of these reagents consist of poliovirus antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify polioviruses from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of poliomyelitis (polio) and provides epidemiological information on this disease. Poliomyelitis is an acute infectious disease which in its serious form affects the central nervous system resulting in atrophy (wasting away) of groups of muscles, ending in contraction and permanent deformity.

• Protein /Albumin Turbidimetric Method (FDA Code: JIQ / 862.1645)

A urinary protein or albumin (nonquantitative) test system is a device intended to identify proteins or albumin in urine. Identification of urinary protein or albumin (nonquantitative) is used in the diagnosis and treatment of disease conditions such as renal or heart diseases or thyroid disorders, which are characterized by proteinuria or albuminuria.

• Q Fever CF Antigen Test (FDA Code: GPS / 866.3500)

Rickettsia serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rickettsia in serum. Additionally, some of these reagents consist of rickettsial antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify rickettsia directly from clinical specimens. The identification aids in the diagnosis of diseases caused by virus-like bacteria belonging to the genusRickettsiae and provides epidemiological information on these diseases. Rickettsia are generally transmitted by arthropods (e.g., ticks and mosquitoes) and produce infections in humans characterized by rash and fever (e.g., typhus fever, spotted fever, Q fever, and trench fever).

• Reovirus 1-3 CF Antigen (FDA Code: GQB / 866.3470)

Reovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to reovirus in serum. The identification aids in the diagnosis of reovirus infections and provides epidemiological information on diseases caused by these viruses. Reoviruses are thought to cause only mild respiratory and gastrointestinal illnesses.

• Respiratory Syncytial CF Antigen (FDA Code: GQG / 866.3480)

Respiratory syncytial virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to respiratory syncytial virus in serum. Additionally, some of these reagents consist of respiratory syncytial virus antisera conjugated with a fluorescent dye (immunofluorescent reagents) and used to identify respiratory syncytial viruses from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of respiratory syncytial virus infections and provides epidemiological information on diseases caused by these viruses. Respiratory syncytial viruses cause a number of respiratory tract infections, including the common cold, pharyngitis, and infantile bronchopneumonia.

• Rubeola CF Antigen (FDA Code: GRJ / 866.3520)

Rubeola (measles) virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubeola virus in serum. The identification aids in the diagnosis of measles and provides epidemiological information on the disease. Measles is an acute, highly infectious disease of the respiratory and reticuloendothelial tissues, particularly in children, characterized by a confluent and blotchy rash.

• Rubeola Enzyme Linked Immunoabsorbent Assay (FDA Code: LJB / 866.3520)

• Salmonella Spp Antigen (FDA Code: GRL / 866.3550)

• Sedimentation Rate Tube (FDA Code: GHC / 864.6700)

• Selective and Differential Culture Media (FDA Code: JSI / 866.2360)

A selective culture medium is a device that consists primarily of liquid or solid biological materials intended for medical purposes to cultivate and identify certain pathogenic microorganisms. The device contains one or more components that suppress the growth of certain microorganisms while either promoting or not affecting the growth of other microorganisms. The device aids in the diagnosis of disease caused by pathogenic microorganisms and also provides epidemiological information on these diseases.

• Shigella Spp Antigen (FDA Code: LIA / 866.3660)

• Specimen Collection Device (FDA Code: LIO / 866.2900)

• Staphylococcus Aureus Somatic Antigen Test (FDA Code: LHT / 866.3700)

• Sterile Specimen Container (FDA Code: FMH / 864.3250)

A specimen transport and storage container, which may be empty or prefilled, is a device intended to contain biological specimens, body waste, or body exudate during storage and transport in order that the matter contained therein can be destroyed or used effectively for diagnostic examination. If prefilled, the device contains a fixative solution or other general purpose reagent to preserve the condition of a biological specimen added to the container. This section does not apply to specimen transport and storage containers that are intended for use as part of an over-the-counter test sample collection system for drugs of abuse testing.

• Streptococcus Spp Antigen (FDA Code: GTY / 866.3740)

• Treponema Pallidum Enzyme Linked Immunoabsorbent Assay (FDA Code: LIP / 866.3830)